Rhenman & Partners Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-130,000
| Closed | -$8.1M | – | 97 |
|
|
2022
Q3 | $8.1M | Sell |
130,000
-195,299
| -60% | -$12.2M | 0.85% | 47 |
|
|
2022
Q2 | $25.9M | Sell |
325,299
-10,538
| -3% | -$841K | 2.95% | 10 |
|
|
2022
Q1 | $35.3M | Sell |
335,837
-89,163
| -21% | -$9.38M | 3.49% | 2 |
|
|
2021
Q4 | $46M | Sell |
425,000
-45,000
| -10% | -$4.87M | 3.06% | 4 |
|
|
2021
Q3 | $51.5M | Sell |
470,000
-55,000
| -10% | -$6.02M | 3.61% | 1 |
|
|
2021
Q2 | $49.2M | Sell |
525,000
-70,000
| -12% | -$6.55M | 3.34% | 2 |
|
|
2021
Q1 | $54.8M | Sell |
595,000
-5,000
| -0.8% | -$460K | 3.82% | 1 |
|
|
2020
Q4 | $43.9M | Sell |
600,000
-95,000
| -14% | -$6.95M | 3.58% | 3 |
|
|
2020
Q3 | $54M | Sell |
695,000
-55,000
| -7% | -$4.27M | 4.8% | 2 |
|
|
2020
Q2 | $41.7M | Sell |
750,000
-250,000
| -25% | -$13.9M | 4.5% | 1 |
|
|
2020
Q1 | $29.6M | Buy |
1,000,000
+225,000
| +29% | +$6.66M | 4.15% | 1 |
|
|
2019
Q4 | $28.1M | Sell |
775,000
-250,000
| -24% | -$9.05M | 3.07% | 4 |
|
|
2019
Q3 | $27.9M | Buy |
+1,025,000
| New | +$27.9M | 3.5% | 2 |
|
|
2019
Q2 | – | Sell |
-939,973
| Closed | -$24.8M | – | 99 |
|
|
2019
Q1 | $24.8M | Sell |
939,973
-6,087
| -0.6% | -$161K | 2.91% | 6 |
|
|
2018
Q4 | $18.5M | Buy |
946,060
+29,009
| +3% | +$567K | 2.11% | 15 |
|
|
2018
Q3 | $18M | Sell |
917,051
-715,161
| -44% | -$14M | 1.8% | 22 |
|
|
2018
Q2 | $27M | Sell |
1,632,212
-375,000
| -19% | -$6.21M | 2.77% | 2 |
|
|
2018
Q1 | $28.5M | Buy |
2,007,212
+52,300
| +3% | +$743K | 3.51% | 1 |
|
|
2017
Q4 | $28.5M | Sell |
1,954,912
-1,051,950
| -35% | -$15.4M | 3.86% | 1 |
|
|
2017
Q3 | $38.1M | Buy |
3,006,862
+584,772
| +24% | +$7.41M | 4.87% | 1 |
|
|
2017
Q2 | $28.8M | Buy |
2,422,090
+670,768
| +38% | +$7.96M | 4.13% | 1 |
|
|
2017
Q1 | $25.9M | Buy |
1,751,322
+1,051,322
| +150% | +$15.5M | 4.1% | 1 |
|
|
2016
Q4 | $11.3M | Buy |
700,000
+335,000
| +92% | +$5.42M | 2.17% | 11 |
|
|
2016
Q3 | $6.62M | Sell |
365,000
-5,000
| -1% | -$90.7K | 1.05% | 37 |
|
|
2016
Q2 | $6.09M | Buy |
370,000
+170,000
| +85% | +$2.8M | 1.08% | 33 |
|
|
2016
Q1 | $3.31M | Buy |
200,000
+54,000
| +37% | +$895K | 0.66% | 54 |
|
|
2015
Q4 | $3.16M | Buy |
+146,000
| New | +$3.16M | 0.48% | 67 |
|